Q2 2025 · 13F-HR
NVP Associates, LLCholdings as filed
Filed 2025-08-14 · accession 0001415889-25-021886
$184.2M
Reported value
7
Positions
2025-06-30
Period end
The Brief · NVP Associates, LLC · Q2 2025
AI · grounded in 13F
NVP Associates, LLC established a new position in DAVE valued at $62.45M. The fund also initiated stakes in OMDA for $46.32M and TALK for $27.25M. Additional new positions include MBX at $24.38M, ZBIO at $17.81M, and GROV at $3.71M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 23834J201 | DAVE | DAVE INC | $62.5M | 33.9% | 232,675 | Common | SOLE |
| 68170A108 | OMDA | OMADA HEALTH INC | $46.3M | 25.2% | 2,531,000 | Common | SOLE |
| 87427V103 | TALK | TALKSPACE INC | $27.3M | 14.8% | 9,802,972 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $24.4M | 13.2% | 2,136,335 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $17.8M | 9.67% | 1,838,482 | Common | SOLE |
| 39957D201 | GROV | GROVE COLLABORATIVE HOLD INC | $3.7M | 2.01% | 3,225,097 | Common | SOLE |
| 683712103 | OPEN | OPENDOOR TECHNOLOGIES INC | $2.2M | 1.21% | 4,189,562 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.